Association Analysis of Serotonin 2A Receptor Gene T102c Polymorphism and Schizophrenia

The serotonin neurotransmitter has been associated with the pathogenesis of mood disorders and schizophrenia. Serotonin receptors genes may therefore be candidate genes for the study of the genetics of these disorders. In this study, patients with schizophrenia (n=235) and controls (nn=344) were analysed to determine the correlation between the 5HT2A receptor gene T102C polymorphism and schizophrenia. No association was found between the studied polymorphism and schizophrenia (pn=0.854 for alleles and pn=0.945 for genotypes). Results were also not significant when analysed by gender (for male p-0.861—allele frequency and pn=0.467—genotype frequency, for female pn=0.857—allele frequency and pn=0.833—genotype frequency). Subgroups with regard to schizophrenia subtypes, age of onset and clinical course of schizophrenia were analysed with negative results.

[1]  M. Rietschel,et al.  Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: Identification of two naturally occurring receptor variants and association analysis in schizophrenia , 1996, Human Genetics.

[2]  J. Leysen,et al.  Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors , 2005, Psychopharmacology.

[3]  H. Meltzer,et al.  A prospective study of clozapine in treatment-resistant schizophrenic patients , 2004, Psychopharmacology.

[4]  Chih-Chiang Chiu,et al.  Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene. , 2002, The American journal of psychiatry.

[5]  B. Sokolov,et al.  Differential expression of the “C” and “T” alleles of the 5‐HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics , 2002, Journal of neuroscience research.

[6]  Tao Li,et al.  No association between T102C polymorphism of serotonin-2A receptor gene and clinical phenotypes of Chinese schizophrenic patients , 2001, Psychiatry Research.

[7]  Paul J. Harrison,et al.  Expression of serotonin 5‐HT2A receptors in the human cerebellum and alterations in schizophrenia , 2001, Synapse.

[8]  E. Tan,et al.  Susceptibility to neuroleptic-induced tardive dyskinesia and the T102C polymorphism in the serotonin type 2A receptor , 2001, Biological Psychiatry.

[9]  J. Joven,et al.  Association study of schizophrenia with polymorphisms at six candidate genes , 2001, Schizophrenia Research.

[10]  B. Thelma,et al.  Family-based association studies of monoaminergic gene polymorphisms among North Indians with schizophrenia , 2001, Molecular Psychiatry.

[11]  J. Lieberman,et al.  Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia , 2001, Molecular Psychiatry.

[12]  B. Lerer,et al.  Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia , 2001, Molecular Psychiatry.

[13]  S. Tsai,et al.  Evidence for an Association between Polymorphism in the Serotonin-2A Receptor Variant (102T/C) and Increment of N100Am plitude in Schizophrenics Treated with Clozapine , 2001, Neuropsychobiology.

[14]  A. Ravindran,et al.  Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. , 2000, American journal of medical genetics.

[15]  B. Sokolov,et al.  Abnormalities in 5‐HT2A receptor mRNA expression in frontal cortex of chronic elderly schizophrenics with varying histories of neuroleptic treatment , 2000, Journal of neuroscience research.

[16]  L. Abramova,et al.  [Serotonin receptor gene allele polymorphism (5HTR2A) and clinical pathogenetic characteristics in patients with schizophrenia and schizophrenia spectrum disorders]. , 2000, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[17]  Kenneth K Kidd,et al.  Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles , 1999, Biological Psychiatry.

[18]  H. Meltzer.  The Role of Serotonin in Antipsychotic Drug Action , 1999, Neuropsychopharmacology.

[19]  Anthony M. Kang,et al.  Global variation of a 40-bp VNTR in the 3′-untranslated region of the dopamine transporter gene (SLC6A3) , 1999, Biological Psychiatry.

[20]  Y. K. Kim,et al.  No association between schizophrenia and serotonin receptor type 2A gene in Korea. , 1999, Psychiatric genetics.

[21]  M. Alda,et al.  T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability. , 1999, Journal of psychiatry & neuroscience : JPN.

[22]  B. Dean,et al.  No Correlation between A(–1438)G Polymorphism in 5-HT2A Receptor Gene Promoter and the Density of Frontal Cortical 5-HT2A Receptors in Schizophrenia , 1999, Human Heredity.

[23]  D. Collier,et al.  102T/C polymorphism of serotonin receptor type 2A gene is not associated with schizophrenia in either Chinese or British populations. , 1999, American journal of medical genetics.

[24]  P. Tu,et al.  No evidence for association of serotonin-2A receptor variant (102T/C) with schizophrenia or clozapine response in a Chinese population. , 1999, Neuroreport.

[25]  Jeffrey A Lieberman,et al.  Serotonin Subtype 2 Receptor Genes and Clinical Response to Clozapine in Schizophrenia Patients , 1998, Neuropsychopharmacology.

[26]  T. Terao,et al.  Negative Association between T102C Polymorphism of the 5-HT2a Receptor Gene and Schizophrenia in Japan , 1998, Human Heredity.

[27]  M. Owen,et al.  A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter , 1998, Molecular Psychiatry.

[28]  D. Collier,et al.  Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine , 1998, Molecular Psychiatry.

[29]  M. Gill,et al.  No association or linkage between the 5-HT2a/T102C polymorphism and schizophrenia in Irish families. , 1997, American journal of medical genetics.

[30]  W. Tsoi,et al.  Association between allele 1 of T102C polymorphism, 5-hydroxytryptamine 2a receptor gene and schizophrenia in Chinese males in Singapore. , 1997, Human heredity.

[31]  E. Smeraldi,et al.  No association between schizophrenia and the serotonin receptor 5HTR2a in an Italian population. , 1997, American journal of medical genetics.

[32]  H. Hwu,et al.  Lack of allelic association between 102T/C polymorphism of serotonin receptor type 2A gene and schizophrenia in Chinese , 1997, Psychiatric genetics.

[33]  A. Malhotra,et al.  Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine. , 1996, The American journal of psychiatry.

[34]  M. Nöthen,et al.  Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene , 1996, The Lancet.

[35]  H. Yoneda,et al.  Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia. , 1996, American journal of medical genetics.

[36]  R. Ganguli,et al.  5‐HT2 receptor gene locus: association with schizophrenia or treatment response not detected , 1996, Psychiatric genetics.

[37]  M. J. Arranz,et al.  Association between clozapine response and allelic variation in 5-HT2A receptor gene , 1995, The Lancet.

[38]  J. Fink,et al.  An MspI polymorphism in the hyman serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis. , 1992, Human molecular genetics.

[39]  J. Shih,et al.  The human 5-HT2 receptor is encoded by a multiple intron-exon gene. , 1992, Brain research. Molecular brain research.

[40]  A. Saltzman,et al.  Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes. , 1991, Biochemical and biophysical research communications.

[41]  H. Meltzer,et al.  The mechanism of action of novel antipsychotic drugs. , 1991, Schizophrenia bulletin.

[42]  L. Cavalli-Sforza,et al.  The serotonin receptor subtype 2 locusHTR2 is on human chromosome 13 near genes for esterase D and retinoblastoma-1 and on mouse chromosome 14 , 1990, Somatic cell and molecular genetics.

[43]  D. Woolley,et al.  A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS. , 1954, Proceedings of the National Academy of Sciences of the United States of America.